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COST EFFECTIVENESS OF SCREENING OF ALL NEWLY RECRUITED 
EMPLOYEES FOR DIABETES AT A TERTIARY CARE HOSPITAL 
Niloufer Sultan Ali, Ali Khan Khuwaja*  
Department of Family Medicine, * Department of Family Medicine and Community Health Sciences, The Aga Khan University, 
Karachi, Pakistan 
Background: Diabetes Mellitus is a disease which remains asymptomatic for long duration of 
time and usually diagnosed either when  gets complicated or by routine or opportunistic screening. 
The practice of universal screening is not recommended, particularly in constraint resources . 
However, we embarked with a study to assess the yield of recommended screening for Type 2 
diabetes in all the newly recruited employees at a tertiary care hospital in Karachi. Methods: All 
the information required for this study was collected from medical records of all newly recruited 
employees of nursing services department of a tertiary care hospital of Karachi, Pakistan, over a 
period of 5 months (August 2004 to December 2004). Out of 360 subjects , 326, whose 
information was found to be complete, were included for final analysis. Results: Mean age of the 
study subjects was 25.3 ± 4.7 years and their mean casual plasma glucose level was 99.1 ± 16.3 
mg/dl. 315 (96.6%) study subjects had casual plasma glucose level of 139 mg/dl or less. Only 10 
(3.1%) study subjects had casual plasma glucose levels between 140 to 199 mg/dl. Just one 
employee, 41 years old, was  found to have casual plasma glucose level of 213 mg/dl. Conclusion: 
In this  study, screening of all individuals for diabetes had a very low yield. Recommendation of 
universal screening for diabetes does not represent a good use of resources and perhaps not cost-
effective. However, periodic screening of high risk individuals should be warranted.  
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INTRODUCTION 
Diabetes Mellitus is a group of metabolic diseases 
characterized by hyperglycemia resulting from 
defects in insulin secretion, insulin action, or both. 
Type 2 diabetes, the most prevalent form of the 
diabetes, is often asymptomatic in its early stages and 
can remain undiagnosed for many years  until 
complications appear or screened.1 Routine  screening 
for diabetes  may be justified with rationale to detect 
it in its earlier stage, to prevent its complication by 
providing prompt and timely management. However, 
screening may be appropriate under certain 
circumstances; as available data do not support 
universal diabetes screening.2,3 It is prudent that 
screening programs of diabetes should be targeted on 
individuals with multiple diabetes risk factors .4-8 The 
greater the number of risk factors present in an 
individual, the greater the chance of that individual 
developing or having diabetes. Conversely, the 
chance of finding diabetes in an individual without a 
risk factor is low. The prevalence of type 2 diabetes , 
steadily increases with advancing age, and it is 
projected that majority of type 2 diabetics will be of 
age 45 years or more. 9 However, there is very low 
yield of detecting diabetes by screening persons 
whose sole risk factor is age.10 Hence, the likelihood 
of identifying an asymptomatic individual with 
diabetes in the general population through random 
screening is low; however in high risk groups the 
likelihood is much higher.  
There are certain criteria for the screening of diabetes 
which are recommended by a large number of 
international organizations and task forces. The 
American Diabetes Association (ADA)4, for 
example, recommends screening for diabetes in 
individuals of age 45 years and above, every three 
years. However, The Staged Diabetes Management, 
Detection and Treatment Quick Guide recommends 
diabetes screening for all people at age 35 and repeat 
every three years.11 Nevertheless, screening should 
also be considered at a younger age in individuals 
with certain risk factors like overweight, family 
history of diabetes (parents and/or siblings), habitual 
physical inactivity, previously identified impaired 
fasting glucose or impaired glucose tolerance, history 
of gestational diabetes and medical illness; 
hypertension, dyslipidemia, polycystic ovary 
syndrome and vascular disease.4,11 These 
recommendations are endorsed by other working 
groups and organizations as well.12 
We undertook a study aimed to assess the 
yield of recommended screening for Type 2 diabetes 
and its cost-effectiveness in all the newly recruited 
employees at a tertiary care hospital.  
MATERIALS AND METHODS 
This study was conducted at the Aga Khan 
University Hospital, a tertiary care, teaching hospital 
in Karachi, Pakistan. Medical records of 360 newly 
recruited employees of nursing services , referred for 
pre-employment screening, over a period of 5 months 
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(August 2004 to December 2004) were assessed.  
Three variables of interest were sex, age and casual 
plasma glucose levels. Out of the total 360 cases, we 
included 326 cases in the final analysis whose 
information was found to be complete.  
The study subjects were predominantly 
females 319 (98%); as expected owing a group of 
nursing employees . Pre-employment screening 
consisted of complete medical, surgical, social 
(including lifestyle), psychological and family 
history, physical examination, Haemoglobin 
estimation, casual plasma glucose level, urine 
microscopy and a chest radiograph.  Employees with 
casual plasma glucose level of more than 200 were 
further investigated according to the guidelines. 
“Casual” was defined as any time of day without 
regard to time since last meal.4   
RESULTS 
Age and plasma glucose levels of study subjects are 
given in Table 1.  Mean age of the study subjects was 
25.3 ± 4.7 years which ranges from 18 to 48 years. 
Mean plasma glucose level of the study subjects was 
99.1 ± 16.3 mg/dl with minimum to maximum range 
of 63 to 213 mg/dl.  
Table 1. Age and plasma glucose levels of study 
subjects (n=326) 
Characteristics Mean ± SD Min – Max 
Age (in years) 25.3 ± 4.7 18 - 48 
Casual Plasma Glucose 
level (in mg/dl) 
99.1 ± 16.3 63 - 213 
Distribution of plasma glucose levels by age groups 
among study subjects is shown in Table 2. In all, 288 
(88%) study subjects were of ages between 18 to 30 
years (Age group 1) while 38 (12%) were of ages 
between 31 to 48 years (Age group 2). A huge 
majority of study subjects 315 (96.6%) had casual 
plasma glucose level of 139 mg/dl or less and is 
almost equally distributed in both age groups. Only 
10 (3.1%) of study subjects had casual plasma 
glucose levels between 140 to 199 mg/dl, again 
equally distributed among both age groups. Only one 
subject, 41 years old, from Age group 2, had casual 
plasma glucose level of > 200 mg/dl.  
Table 2. Distribution of casual plasma glucose 
levels by age groups among study subjects (n=326) 
Casual 
Plasma 
Glucose level  
Total 
(n = 326) 
Age group 1  
(n = 288) 
Age group 2  
(n = 38) 
= 139 mg/dl 315 (96.6%) 279 (96.9%) 36 (94.7%) 
140 to 199 mg/dl 10 (3.1%) 09 (3.1%) 01 (2.6%) 
= 200 mg/dl 01 (0.3%) 00 (0.0%) 01 (2.6%) 
 
DISCUSSION 
We reviewed the current practice of casual plasma 
glucose testing on every newly recruited employee to 
assess its validity, thus cost-effectiveness. The results 
of this study will help in formulating policies and 
recommendations for screening for diabetes , among 
all newly recruited employees , and will also make a 
ground for further work and research in this regard.  
Screening for Type 2 diabetes would allow 
earlier recognition of cases, with the potential to 
intervene earlier in the disease course, but whether 
this would result in improved long-term outcomes is 
unknown.13 There is currently no direct evidence as 
to whether individuals will or will not benefit from 
early detection of Type 2 diabetes through 
screening.14  However, it is suggested that screening 
programs targeting individuals with multiple diabetes 
risk factors be worthwhile and cost-effective.4-8 
Universal screening for Type 2 diabetes is not a 
rationale,2,3 thus not recommended. Increasing age, 
being a sole risk factor for Type 2 diabetes , screening 
has documented a very low yield.10 In this  study, we 
have found only one study subject who had casual 
plasma level of 213 mg/dl, which is more than 
recommended as normal and when we cross 
tabulated, that particular newly employee was of age 
more than 40 years.    
There is no evidence to demonstrate the 
benefit and cost-effectiveness of early screening of 
all newly recruited employees  to reduce the 
morbidity and mortality associated with diabetes in 
presumably healthy individuals  having no risk factors 
and at younger age than recommended. Such 
screening recommendation usually does not translate 
a good use of resources. However, periodic screening 
of high risk individuals as part of ongoing medical 
care may be warranted rather than merely a single 
one time effort. 
There are some limitations of this study 
which should be kept in mind before generalizing its 
results to all populations. First, the recommended 
initial screening test of diabetes for non pregnant 
adult females is fasting plasma glucose while in this 
study casual plasma glucose test was used for the 
sake of convenience. Secondly, the study was 
conducted among certain specified group of 
employees (Nursing services).  
CONCLUSION  
Despite of these limitations, to increase the cost-
effectiveness of screening for diabetes, testing should 
be considered in high risk subjects . To be more 
liberal, it could be recommended that only those who 
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are 35 years of age and above and  below 35 years of 
age with risk factors, be screened for diabetes by a 
standard fasting plasma glucose test at the time of 
recruitment and a periodic screening as part of 
ongoing medical care. Also, clinicians should be 
vigilant in evaluating clinical presentation suggestive 
of diabetes at the time of recruitment and on ongoing 
basis. We also suggest further research to explore and 
study the cost-effectiveness and rationale 
recommendations for screening for diabetes in 
resource constraint countries  like ours.  
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